MedPath

CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE

🇮🇹Italy
Ownership
-
Established
2000-01-01
Employees
-
Market Cap
-
Website
http://www.cvbf.net/

Clinical Trials

7

Active:5
Completed:2

Trial Phases

3 Phases

Phase 1:3
Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (60.0%)
Phase 2
1 (20.0%)
Phase 3
1 (20.0%)

Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Phase 3
Completed
Conditions
Chronic Iron Overload
Interventions
First Posted Date
2013-04-05
Last Posted Date
2021-05-04
Lead Sponsor
Consorzio per Valutazioni Biologiche e Farmacologiche
Target Recruit Count
435
Registration Number
NCT01825512
Locations
🇦🇱

Hospital 'Ihsan Çabej', Lushnjë, Albania

🇦🇱

Qendra Spitalore Universitare "Nene Tereza" Tirane, Tirana, Albania

🇨🇾

Department of Medical and Public health Services of the Ministry of Health, Nicosia, Cyprus

and more 19 locations

Pharmacokinetic Study of Deferiprone in Paediatric Patients

Phase 2
Completed
Conditions
Chronic Iron Overload
Interventions
Drug: Deferiprone, dose level 2
Drug: Deferiprone, dose level 1
Drug: Deferiprone, dose level 3
First Posted Date
2012-12-04
Last Posted Date
2017-01-11
Lead Sponsor
Consorzio per Valutazioni Biologiche e Farmacologiche
Target Recruit Count
23
Registration Number
NCT01740713
Locations
🇨🇾

Department of Medical and Public Health Services of the Ministry of Health, Nicosia, Cyprus

🇪🇬

Cairo Univesity Paediatric Hospital, Cairo, Egypt

🇮🇹

Azienda Ospedaliero-Universitaria Consorziale, Bari, Italy

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.